Mark Van Camp

829 total citations
12 papers, 641 citations indexed

About

Mark Van Camp is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Mark Van Camp has authored 12 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Mark Van Camp's work include Vitamin D Research Studies (7 papers), Cancer-related Molecular Pathways (6 papers) and Estrogen and related hormone effects (4 papers). Mark Van Camp is often cited by papers focused on Vitamin D Research Studies (7 papers), Cancer-related Molecular Pathways (6 papers) and Estrogen and related hormone effects (4 papers). Mark Van Camp collaborates with scholars based in Belgium, Germany and Netherlands. Mark Van Camp's co-authors include Roger Bouillon, Annemieke Verstuyf, Lieve Verlinden, Geert Carmeliet, Guy Eelen, Katharina Ribbeck, Nico Smets, Jan Ellenberg, Ingrid Stockmans and Tim Raemaekers and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Journal of Bone and Mineral Research.

In The Last Decade

Mark Van Camp

12 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Van Camp Belgium 11 309 309 158 140 120 12 641
Christina Mørk Hansen Denmark 14 264 0.9× 434 1.4× 257 1.6× 192 1.4× 71 0.6× 20 686
Salimuddin Shah United States 6 410 1.3× 179 0.6× 166 1.1× 140 1.0× 50 0.4× 7 645
Jane S. Green Canada 7 353 1.1× 251 0.8× 406 2.6× 173 1.2× 113 0.9× 7 808
Fatemeh Davoodi United States 6 146 0.5× 327 1.1× 182 1.2× 150 1.1× 38 0.3× 9 516
Ruth Frampton Australia 7 217 0.7× 239 0.8× 170 1.1× 154 1.1× 51 0.4× 16 548
Tara C. Polek United States 11 282 0.9× 246 0.8× 208 1.3× 128 0.9× 27 0.2× 11 646
Maura Simboli-Campbell Canada 8 164 0.5× 282 0.9× 179 1.1× 129 0.9× 30 0.3× 10 456
Elżbieta Gocek Poland 15 458 1.5× 223 0.7× 98 0.6× 123 0.9× 28 0.2× 20 757
Hirofumi Akashi Japan 11 329 1.1× 110 0.4× 69 0.4× 140 1.0× 42 0.3× 17 573
Bryan M. Gillard United States 12 320 1.0× 151 0.5× 65 0.4× 137 1.0× 25 0.2× 25 615

Countries citing papers authored by Mark Van Camp

Since Specialization
Citations

This map shows the geographic impact of Mark Van Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Van Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Van Camp more than expected).

Fields of papers citing papers by Mark Van Camp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Van Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Van Camp. The network helps show where Mark Van Camp may publish in the future.

Co-authorship network of co-authors of Mark Van Camp

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Van Camp. A scholar is included among the top collaborators of Mark Van Camp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Van Camp. Mark Van Camp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Verlinden, Lieve, Carsten Kriebitzsch, Guy Eelen, et al.. (2012). The odd-skipped related genes Osr1 and Osr2 are induced by 1,25-dihydroxyvitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 136. 94–97. 11 indexed citations
2.
Kriebitzsch, Carsten, Lieve Verlinden, Guy Eelen, et al.. (2010). REGULATION OF CYSTATHIONINE BETA SYNTHASE BY 1α,25-DIHYDROXYVITAMIN D3. Bone. 46. S51–S51. 2 indexed citations
3.
Kriebitzsch, Carsten, Lieve Verlinden, Guy Eelen, et al.. (2009). The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach.. PubMed. 29(9). 3471–83. 38 indexed citations
4.
Verlinden, Lieve, Guy Eelen, Kristof Engelen, et al.. (2006). 1α,25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 411–415. 14 indexed citations
5.
Verlinden, Lieve, Guy Eelen, Mark Van Camp, et al.. (2005). Characterization of the Condensin Component Cnap1 and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D3. Journal of Biological Chemistry. 280(45). 37319–37330. 38 indexed citations
6.
Eelen, Guy, Lieve Verlinden, Mark Van Camp, et al.. (2005). Altered Vitamin D receptor–coactivator interactions reflect superagonism of Vitamin D analogs. The Journal of Steroid Biochemistry and Molecular Biology. 97(1-2). 65–68. 10 indexed citations
7.
Eelen, Guy, Lieve Verlinden, Mark Van Camp, et al.. (2004). Microarray analysis of 1α,25-dihydroxyvitamin D3-treated MC3T3-E1 cells. The Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5). 405–407. 21 indexed citations
8.
Eelen, Guy, Lieve Verlinden, Mark Van Camp, et al.. (2004). The Effects of 1α,25-Dihydroxyvitamin D3 on the Expression of DNA Replication Genes. Journal of Bone and Mineral Research. 19(1). 133–146. 58 indexed citations
9.
Raemaekers, Tim, Katharina Ribbeck, Joël Beaudouin, et al.. (2003). NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. The Journal of Cell Biology. 162(6). 1017–1029. 190 indexed citations
10.
Verlinden, Lieve, Annemieke Verstuyf, Marcus Quack, et al.. (2001). Interaction of Two Novel 14-Epivitamin D3 Analogs with Vitamin D3 Receptor-Retinoid X Receptor Heterodimers on Vitamin D3 Responsive Elements. Journal of Bone and Mineral Research. 16(4). 625–638. 25 indexed citations
11.
Verlinden, Lieve, Annemieke Verstuyf, Mark Van Camp, et al.. (2000). Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.. PubMed. 60(10). 2673–9. 106 indexed citations
12.
Verlinden, Lieve, et al.. (1998). Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Molecular and Cellular Endocrinology. 142(1-2). 57–65. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026